1
FOSAMAX PLUS and FOSAMAX PLUS D Re-examination Study (0217A-267)
Condition(s):OsteoporosisLast Updated:February 3, 2022Completed
FOSAMAX: 213 Clinical Trials, Page 1 of 22
Hide Studies Not Open or Pending
2
Pilot Study of Fosamax in Spinal Cord Injury
Condition(s):Spinal Cord Injury; OsteoporosisLast Updated:January 29, 2016Terminated
3
Bioequivalence Study of Alendronate Sodium Tablets 70 mg of Dr. Reddy’s Under Fasting Conditions
Condition(s):HealthyLast Updated:June 14, 2010Completed
4
Alendronate in Juvenile Osteoporosis
Condition(s):Juvenile Osteoporosis; Low Bone Density; FracturesLast Updated:July 11, 2018Completed
5
The Effects of Alendronate After Cure of Primary Hyperparathyroidism
Condition(s):HyperparathyroidismLast Updated:November 16, 2011Withdrawn
6
Predictive Value of Bone Turnover Markers During Discontinuation With Alendronate
Condition(s):OsteoporosisLast Updated:March 18, 2021Completed
7
The Effect of Effervescent Alendronate on Bone Turnover
Condition(s):Osteopenia or OsteoporosisLast Updated:April 13, 2022Active, not recruiting
8
Phase IV Clinical Trial to Evaluate Efficacy and Safety of MASI BONE S (Alendronate Sodium Trihydrate) in Postmenopausal Women With Osteoporosis
Condition(s):OsteoporosisLast Updated:May 31, 2022Recruiting
9
Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis
Condition(s):OsteoporosisLast Updated:January 19, 2011Completed
10
Efficacy and Safety Study of Fosamax Plus D in Postmenopausal Women With Osteoporosis (0217A-263)
Condition(s):Osteoporosis PostmenopausalLast Updated:February 8, 2022Completed